Soliddd Corp., an optical technology company whose mission is to restore sight for people living with low vision disorders, announced that it will be unveiling the Beta version of its forthcoming ...

Furthermore, Dr. Sherif’s presentation will highlight upcoming near-term milestones, including the topline results from the ACUITY Phase 2 trial with OCS-05 for the treatment of acute optic neuritis, ...

Dietitian Juliette Kellow reveals why eggs are a cracking food to always have in your kitchen and their all-round goodness ...

Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascendi ...

Innovate Retina focuses exclusively on game-changing innovations in medical and surgical retina care, including current management of age-related macular degeneration (AMD) and diabetic ...

Half of people who develop blood poisoning, otherwise known as sepsis, are dead within a couple of years, a new study finds.

“The book I’m working on, called ‘My License to Fail’, is 350 pages, with big drawings because I have acute macular degeneration so I have to work big to see what I’m doing,” he added.

The evidence also informed Zephyrm’s targeting of acute respiratory distress syndrome ... for Parkinson’s disease, age-related macular degeneration (AMD) and corneal endothelium decompensation ...

The Icahn School of Medicine has announced a $5 million gift from the John and Daria Barry Foundation for the Center for ...

Next in the pipeline is OCS-05, a disease-modifying candidate for acute optic neuritis (AON ... in advanced Dry Age-related Macular Degeneration (Dry AMD). A pivotal global phase III trial ...